|
BR122021024395A2
(enExample)
|
|
|
|
BR122021000189A2
(enExample)
|
|
|
|
BR112019008823A2
(enExample)
|
|
|
|
BR112020006084A8
(enExample)
|
|
|
|
BR122022025811B8
(enExample)
|
|
|
|
BR122022008542B1
(pt)
|
|
Uso de um composto e composição farmacêutica o compreendendo
|
|
BR122021023687A2
(enExample)
|
|
|
|
BR122021014832A2
(enExample)
|
|
|
|
BR122022003522A2
(enExample)
|
|
|
|
BR112020008820A2
(enExample)
|
|
|
|
BR202017020981U2
(enExample)
|
|
|
|
BR202017017068U2
(enExample)
|
|
|
|
BR202017016984U2
(enExample)
|
|
|
|
BR202017016924U2
(enExample)
|
|
|
|
BR202017012548U2
(enExample)
|
|
|
|
BR202017011220U2
(enExample)
|
|
|
|
BR202017010814U2
(enExample)
|
|
|
|
BR202017010373U2
(enExample)
|
|
|
|
BR202017009870U2
(enExample)
|
|
|
|
BR202017006953U2
(enExample)
|
|
|
|
BR202017004898U2
(enExample)
|
|
|
|
BR202017002937U2
(enExample)
|
|
|
|
BR202017002826U2
(enExample)
|
|
|
|
CN303996861S
(enExample)
|
|
|
|
CN304004421S
(enExample)
|
|
|